The benefits of sunflower oleodistillate (SOD) in pediatric dermatology

Pediatric Dermatology

Volumn 26, Issue 6, 2009, Pages 669-675

  Eichenfield, Lawrence F ^a   McCollum, Alexandra ^a   Msika, Philippe ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b Innovation Research and Development Department   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CEREBROSIDE; CLOFIBRATE; CORTICOSTEROID; CYTOKINE; DESONIDE; FLUOCINOLONE ACETONIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LANOLIN ALCOHOL; LINOLEIC ACID; MESSENGER RNA; MINERAL OIL; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PETROLATUM; PHYTOSTEROL; PIRINIXIC ACID; PROSTAGLANDIN E2; SOLVENT; STEARIC ACID; STELATOPIA; SUNFLOWER OIL; SUNFLOWER OLEODISTILLATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CLINICAL EVALUATION; CLINICAL TRIAL; CREAM; DERMATOLOGY; DISTILLATION; DRUG MECHANISM; DRY SKIN; EMULSION; ESSENTIAL FATTY ACID DEFICIENCY; HISTOLOGY; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INFANT MORTALITY; INFLAMMATION; KERATINOCYTE; LICHENOID ERUPTION; LIPID METABOLISM; LIPOGENESIS; MASSAGE; OVERALL SURVIVAL; PEDIATRICS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SKIN; SKIN WATER LOSS; SUNFLOWER; SURVIVAL RATE; XEROSIS;

ADMINISTRATION, TOPICAL; ANIMALS; CHILD; DISTILLATION; HUMANS; PLANT EXTRACTS; PLANT OILS; SKIN; SKIN DISEASES;

EID: 73449126550     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.01042.x     Document Type: Review

References (41)

1. Leyden JJ, Baumann LS, Downie JB, Draelos ZD. Highlights of a symposium: the role of natural ingredients in dermatology. Skin & Allergy News 2004 35 (Suppl. 1 4.
2. Elmets CA, Singh D, Tubesing K et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 2001 44 : 425 432.
3. Bergfeld WF, Fowler JF, Baumann LS et al. The four seasons of skin care: the utility of natural ingredients. Cos Derm 2004 17 (Suppl. 4 1 9.
4. Yokota T, Nishio H, Kubota Y et al. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 1998 11 : 355 361.
5. Kang S, Chung JH, Lee JH et al. Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signaling that leads to photoaging in human skin in vivo. J Invest Dermatol 2003 120 : 835 841.
6. Pinnell SR. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 2003 48 : 1 19. quiz 20-12.
7. Lopez Perez G, Torres Altamirano M. Indications for sunflower oil concentrate in the treatment of atopic dermatitis. Rev Alerg Mex 2006 53 : 217 225.
8. Press M, Hartop PJ, Prottey C. Correction of essential fatty-acid deficiency in man by the cutaneous application of sunflower-seed oil. Lancet 1974 1 : 597 598.
9. Prottey C, Hartop PJ, Press M. Correction of the cutaneous manifestations of essential fatty acid deficiency in man by application of sunflower-seed oil to the skin. J Invest Dermatol 1975 64 : 228 234.
10. Prottey C. Essential fatty acids and the skin. Br J Dermatol 1976 94 : 579 587.
11. Elias PM, Brown BE, Ziboh VA. The permeability barrier in essential fatty acid deficiency: evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol 1980 74 : 230 233.
12. Goldyne ME. Prostaglandins and cutaneous inflammation. J Invest Dermatol 1975 64 : 377 385.
13. Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther 2004 17 (Suppl. 1 6 15.
14. Elias PM. Epidermal lipids, barrier function and desquamation. J Invest Dermatol 1983 80 (Suppl. 44 49.
15. Van Dorp DA. Essential fatty acids and prostaglandins. 24th International Congress of Pure and Applied Chemistry, Vol. 2:117. London : Butterworth, 1974.
16. Van Stratum PGC, Gottenbos JJ, Nugteren DH et al. Essential fatty acids and prostaglandins. 24th International Congress of Pure and Applied Chemistry, Vol. 2:117. London : Butterworth. 1974.
17. Darmstadt GL, Saha SK, Ahmed AS et al. Effect of topical treatment with skin barrier-enhancing emollients on nosocomial infections in preterm infants in Bangladesh: a randomised controlled trial. Lancet 2005 365 : 1039 1045.
18. Darmstadt GL, Saha SK, Ahmed AS et al. Effect of skin barrier therapy on neonatal mortality rates in preterm infants in Bangladesh: a randomized, controlled, clinical trial. Pediatrics 2008 121 : 522 529.
19. Nachbar F, Korting HC. The role of vitamin E in normal and damaged skin. J Mol Med 1995 73 : 7 17.
20. Yasukawa K, Takido M, Matsumoto T et al. Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stage carcinogenesis. Oncology 1991 48 : 72 76.
21. Rahman S, Bhatia K, Khan AQ et al. Topically applied vitamin E prevents massive cutaneous inflammatory and oxidative stress responses induced by double application of 12-O-tetradecanoylphorbol-13-acetate (TPA) in mice. Chem Biol Interact 2008 172 : 195 205.
22. Msika P, De Belilovsky C, Piccardi N et al. New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. Pediatr Dermatol 2008 25 : 606 612.
23. Piccardi N, Piccirilli A, Choulot JC, Msika P. Sunflower oil oleodistillate for atopy treatment: an in vitro and clinical evaluation. J Invest Dermatol. 2001 117 (2) : 390 423. [Abstract 169]
24. Dubuquoy L, Piccardi N, Msika P et al. Sunflower oleodistillate a new natural PPAR alpha activator with anti-inflammatory properties. J Invest Dermatol. 2005 124 (4 Suppl.) [Abstract 349]
25. Kuenzli S, Saurat JH. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol 2003 149 : 229 236.
26. Hanley K, Jiang Y, He SS et al. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha. J Invest Dermatol 1998 110 : 368 375. (Pubitemid 28158652)
27. Hanley K, Jiang Y, Crumrine D et al. Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 1997 100 : 705 712.
28. Komuves LG, Hanley K, Jiang Y et al. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol 1998 111 : 429 433.
29. Sheu MY, Fowler AJ, Kao J et al. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 2002 118 : 94 101.
30. Kippenberger S, Loitsch SM, Grundmann-Kollmann M et al. Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation. J Invest Dermatol 2001 117 : 1430 1436.
31. Rivier M, Castiel I, Safonova I et al. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. J Invest Dermatol 2000 114 : 681 687.
32. Guttman-Yassky E. Atopic dermatitis. Curr Probl Dermatol 2007 35 : 154 172.
33. Cambazard F, Guillet G, de Belilovsky C et al. Atopia: atopic dermatitis in more than 3000 young children. Epidemiology and management in Europe. Poster presented at 10th Meeting of Practical Pediatrics, Paris, France, January 27-28, 2006.
34. Absolon CM, Cottrell D, Eldridge SM et al. Psychological disturbance in atopic eczema: the extent of the problem in school-aged children. Br J Dermatol 1997 137 : 241 245.
35. Hanifin JM, Cooper KD, Ho VC et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines." J Am Acad Dermatol 2004 50 : 391 404.
36. Kolbe L, Kligman AM, Schreiner V et al. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 2001 7 : 73 77.
37. Kao JS, Fluhr JW, Man MQ et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003 120 : 456 464.
38. Imokawa G. Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 2001 45 (1 Suppl. S29 S32.
39. Staumont-Salle D, Abboud G, Brenuchon C et al. Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis. J Allergy Clin Immunol 2008 121 : 962 968 e966.
40. Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001 144 : 104 110.
41. Lawson V, Lewis-Jones MS, Finlay AY et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998 138 : 107 113.